Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof
AssigneeChiron Corporation
InventorsDavid Ring, Tian-Xiang Shi
Life of this patent
Estimating the term…
Abstract
This invention relates generally to the field of immunology, in particular that of antibodies and antibody productions. More specifically, this invention relates to bispecific antibodies, the hybrid hybridomas which produce them, the parent hybridomas, the production and selection of the hybridomas and hybrid hybridomas, and the purification of the bispecific antibodies. Specific examples relate to bispecific monoclonal antibodies which recognize both the human multi-drug resistance antigen, P-glycoprotein and human Fc.gamma. receptor III (hFc.gamma.RIII. These bispecific antibodies are useful in killing cancer cells.
Claims3
Hybridoma cell line 17F9 (ATCC Patent Deposit Designation PTA-354), or progeny thereof.
Dependencies are inferred from the claim text.